Cytokinetics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
30,648.00
46,940.00
28,658.00
106,407.00
13,368.00
31,501
SG&A Expense
64,109.00
61,204.00
65,476.00
91,479.00
124,864.00
119,178
EBIT
33,894.00
14,754.00
37,407.00
14,187.00
113,396.00
88,916
Unusual Expense
-
-
-
4,500.00
-
-
Non Operating Income/Expense
79.00
-
-
-
-
-
Interest Expense
-
-
250.00
2,698.00
16,996.00
21,564
Pretax Income
33,717.00
14,646.00
37,501.00
16,453.00
127,790.00
106,289
Consolidated Net Income
33,717.00
14,646.00
37,501.00
16,453.00
127,790.00
106,289
Net Income
33,717.00
14,646.00
37,501.00
16,453.00
127,790.00
106,289
Net Income After Extraordinaries
33,717.00
14,646.00
37,501.00
16,453.00
127,790.00
106,289
Net Income Available to Common
33,717.00
14,646.00
37,501.00
16,453.00
127,790.00
106,289
EPS (Basic)
1.24
0.41
0.97
0.39
2.59
1.95
Basic Shares Outstanding
27,275.00
35,709.00
38,814.00
39,943.00
49,404.00
54,420
EPS (Diluted)
1.24
0.41
0.97
0.39
2.59
1.95
Diluted Shares Outstanding
27,275.00
35,709.00
38,814.00
42,561.00
49,404.00
54,420
EBITDA
33,461.00
14,264.00
36,818.00
14,928.00
111,496.00
87,677
Non-Operating Interest Income
98.00
108.00
156.00
464.00
2,602.00
4,191
About Cytokinetics
View Profile
